Luis Mora, DPM
Foot Surgery · Staten Island, NYNPI 1356576961
Payments from drug & device makers
Across 37 payments — averaging $40.29 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ortho Dermatologics, A Division Of Bausch Health US, LLC$398
- Amgen$368
- Advanced Oxygen Therapy Inc.$287
- Celularity Inc.$114
- Paratek Pharmaceuticals, Inc.$93
- Treace Medical Concepts, Inc.$68
- plus $162 from 5 others
What the payments were for
- Food & beverage$1,491100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 17 | $398 |
| Amgen | 5 | $368 |
| Advanced Oxygen Therapy Inc. | 3 | $287 |
| Celularity Inc. | 1 | $114 |
| Paratek Pharmaceuticals, Inc. | 2 | $93 |
| Treace Medical Concepts, Inc. | 3 | $68 |
| Polynovo North America LLC | 1 | $48 |
| Stryker | 1 | $39 |
| Smith+Nephew | 2 | $38 |
| Melinta Therapeutics, LLC | 1 | $19 |
| Sebela Pharmaceuticals Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KRYSTEXXA$345
- Topical oxygen chamber for extremities$269
- JUBLIA$123
- Biovance$114
How this compares
$1,491 in reported general payments places this provider in the 70th percentile of 294 foot surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Tavaborole | 85 | $29,423 |
| Ammonium Lactate | 43 | $1,020 |
| Diclofenac Sodium | 16 | $941 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 32 | $801 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 26 | $152 |
| Methylprednisolone | 18 | $110 |
| Mupirocin | 14 | $84 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 12 | $63 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Staten Island
- Gledi PecoStaten Island$8K
- Mina BeshaiStaten Island$3K
- Ronald GubermanRidgewood$337K
- John JackaloneBethpage$66K
- David WongBronx$45K
- Berdj StepanianWhite Plains$26K
- Lawrence SantiBrooklyn$25K
- David GitlinBayside$24K
- Rick DelmonteNew York$21K
- Corrine RenneFranklin Square$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.